Home LiteratureArticle Details
PMID: 11986422 Published · ppublish English Letter Comment

Irinotecan in small-cell lung cancer.

The New England journal of medicine ·Vol. 346 ·No. 18 ·2002-05-02 ·Pages 1414-5; author reply 1414-5

Ando Y, Figg WD

Abstract

暂无摘要

MeSH Terms
Antineoplastic Agents, Phytogenic/administration & dosage,adverse effects Antineoplastic Combined Chemotherapy Protocols/therapeutic use Camptothecin/administration & dosage,adverse effects,analogs & derivatives Carcinoma, Small Cell/drug therapy,genetics Glucuronosyltransferase/genetics Irinotecan Lung Neoplasms/drug therapy,genetics Polymorphism, Genetic Prodrugs/adverse effects
Chemicals
Antineoplastic Agents, Phytogenic Prodrugs Irinotecan Glucuronosyltransferase Camptothecin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Ando Yuichi
Figg William D
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
DOI
10.1056/NEJM200205023461818
Published
2002-05-02
Pages
1414-5; author reply 1414-5
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 11784874
External Links
PubMed source DOI: 10.1056/NEJM200205023461818 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2